The ratings affirmation is based on a variety of factors, including MHS’ leading market position, sound debt coverage and still adequate liquidity.
The outlook is stable, reflecting Moody’s Investors Service’s expectation MHS’ performance will show some improvement throughout fiscal year 2017 and operations will at least meet budgeted expectations.
More articles on healthcare finance:
OmniSYS acquires voiceTech
Arizona Senate approves bill to fight surprise medical billing
S&P lowers rating to ‘BBB+’ on St. Anthony’s Medical Center’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
